The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 trial of the CDK4 inhibitor dalpiciclib in well-differentiated or dedifferentiated liposarcoma.
 
Zengjun Liu
No Relationships to Disclose
 
Mengyao Liu
No Relationships to Disclose
 
Jing Xu
No Relationships to Disclose
 
Wenyu Hu
No Relationships to Disclose
 
Hui Zhang
No Relationships to Disclose
 
Rongjie Tao
No Relationships to Disclose
 
Xinyu Li
No Relationships to Disclose
 
Lichao Cha
No Relationships to Disclose
 
Jinfang Cui
No Relationships to Disclose
 
Junkai Zhao
No Relationships to Disclose
 
Heng Fu
No Relationships to Disclose
 
Chunxiang Fan
No Relationships to Disclose
 
Lantian Tian
No Relationships to Disclose
 
Fabo Qiu
No Relationships to Disclose
 
Dongyuan Zhu
No Relationships to Disclose